MHRA approves Bristol Myers Squibb’s Opdualag for advanced melanoma treatment
The American biopharmaceutical company receives marketing authorisation for the drug through Project Orbis
 The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved...